Home page > News and press release

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data
Chiesi accelerates path toward full sustainability despite Covid-19 pandemic
Ensuring continuing medical treatment for patients has been top priority during Covid-19 pandemic. Focus on Diversity & Inclusion in the workplace: 53% of all employees are women – ratio...
Chiesi Group receives the European marketing authorisation for Trimbow® (beclometasone dipropionate, formoterol fumarate, glycopyrronium) an extrafine formulation fixed triple combination therapy for the treatment of asthma
Chiesi Group increases support measures and announces new funds for employees, patients and healthcare providers in response to COVID- 19 pandemic
Chiesi Group Announces Establishment of New Global Rare Diseases Division